Biohaven Ltd. SEC filings BHVN
Biohaven Ltd. has 282 filings in SEC EDGAR's recent list, going back to Jul 1, 2022. Its latest annual report, Form 10-K, was filed on Mar 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Mar 13, 2026 | — |
| DEF 14A | Proxy statement | Mar 13, 2026 | Apr 28, 2026 |
| DEFA14A | Additional proxy material | Mar 18, 2025 | — |
| DEF 14A | Proxy statement | Mar 18, 2025 | May 5, 2025 |
| DEFA14A | Additional proxy material | Mar 18, 2024 | — |
| DEF 14A | Proxy statement | Mar 18, 2024 | Apr 30, 2024 |
| DEFA14A | Additional proxy material | Mar 23, 2023 | — |
| DEF 14A | Proxy statement | Mar 23, 2023 | May 2, 2023 |
Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BHVN (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Virgin Islands, British
- Headquarters
- New Haven, CT
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1935979
- Former names
- Biohaven Research Ltd. (until Sep 14, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.